 |
Blood filter for sepsis: A microfluidic prototype selectively draws out infectious pathogens as blood flows through. The top image shows blood flow from left to right through the device. Without a magnetic field (top), red blood cells (red) and pathogens (yellow) pass in and out of the device together. In the presence of a magnet (bottom), the pathogens bind to magnetic beads (green), separating from blood into different channels. Researchers say that such a device may help clean large volumes of blood, particularly in cases of severe sepsis.
Credit: Shannon Xia and Don Ingber
|
Each year, intensive care units in the United States hospitalize nearly 750,000 patients with severe sepsis, a syndrome that manifests when a body's immune system overreacts to infection. As sepsis sets in, inflammation rapidly spreads through the body, often shutting down organs and potentially leading to death. Antibiotics are often the main course of treatment, but there's a lag time before the drugs kick in, during which inflammation continues to spread.
Now scientists at Children's Hospital Boston are developing a miniature filtration device that can rapidly pump blood out of the body, clearing it of infectious agents before delivering the blood back to the body. Principal investigator Donald Ingber says that the microfluidic device can be used in combination with antibiotics as a first line of defense in treating sepsis before the antibiotics take effect.
"The goal is to clear the blood in a period of hours," says Ingber. "You really have a tipping point, and we want to try to get over that point so that the antibiotics can kick in."
Ingber and his collaborators from Harvard Medical School, Boston University, and the Charles Stark Draper Laboratory have designed a prototype that is able to pull pathogens out of blood as it flows through a microscopic filtration system. Ingber says that the device improves on current blood filtration methods such as hemodialysis. Dialysis machines filter blood by pumping it out through a catheter and into a compartment with a semipermeable membrane. On the other side of the membrane is a compartment with fluid flowing in the opposite direction. Via forces of diffusion and osmosis, small, unwanted molecules from blood cross the membrane, exiting with the fluid as the filtered blood flows back into the body.
While dialyzers can filter small molecules out of blood, larger molecules such as pathogens are too big to cross. Instead, Ingber and his colleagues designed a small microfluidic device that pulls these larger pathogens out of blood.
The device itself contains a pair of microscopic channels--one for blood, the other for a saline-based solution. The two channels meet in a central compartment. The idea is to give the saline solution properties that will selectively draw pathogens out of blood as the two fluids mix.
However, because of their very small scale, microfluidic devices have no moving parts that can mechanically mix fluids together. Even as they come in contact, fluids will remain discrete, retaining their respective molecules. Then Ingber hit upon the idea to use a small magnetic field. He first identified specific molecules that naturally bind to certain pathogens related to sepsis. Ingber and his colleagues then coated these molecules with tiny magnetic beads in solution. They then pumped the solution through one channel as infected blood was pumped through the other. As the two channels funneled into one compartment, the team turned on a small magnet on the side of the magnetic bead solution. As the fluids came in contact, the pathogens from the blood bound with the magnetically coated molecules, which in turn were pulled toward the magnet, away from the blood flow.
Comments
nekote on 05/23/2008 at 3:24 AM
115
Top image (actually the right image)?
blood flow from left to right (rather than top to bottom)?
Presence of a magnet in (bottom [image?]) actually left image?
Rotate pair of images counter clockwise, 90 degrees?
What is the value /purpose of the microfluidic channels?
Why not simply pass blood over / through surfaces coated with the key pathogen receptor molecules? Like sticking flys to fly paper.
Alternatively, have those key pathogen receptor molecules on the surface of particles that can be filtered / channeled by their comparatively "large" size? Or magnetism (if part of the particle is or can be induced to be magnetic)? Or other means of discriminating?
Such selective filtering methods could be quickly, easily and readily adapted to, say, existing pheresis machines (that remove / filter platelets from donors and return the remainder of the blood back to the donor) or dialysis machines?
cyberpageman on 05/23/2008 at 10:34 AM
24
As I understand the sepsis filtration, microfluidic channels are used because the pathogens have to diffuse out of the blood. Diffusion is slow. The microfluidic device compensates for the slow diffusion by using only a short pathlength over which the pathogens have to diffuse. A micro device also has the advantage of requiring only a relatively small magnet to provide an efficient high-gradient magnetic field to pull the magnetized particles out of solution.
The pathogen-receptor-coated surface idea would work for a limited time, but would become saturated. The microfluidic device provides a constant source of a fresh "surface" in the form of a stream of coated particles so saturation does not become a problem.
The Children's Hospital group have done a good job in developing their system. Hopefully they will be able to scale it up so it will be useful clinically.
nekote on 05/24/2008 at 6:14 AM
115
For a magnetic / size particle type method, I was thinking there would be a constantly added "drip" of particles mixed into the blood stream from the donor and that absolutely 100% of those particles would be removed, before the blood was returned to the donor.
For a surface coated method, one time use disposable media. It would be best, of course, if there was some sort of (visual) indication of capture / utilization / "fullness".
bkf11 on 05/28/2008 at 12:19 AM
6
The advantage may be that the microfluidic device actually -removes- the pathogens from the blood stream so that toxins that the pathogen may be producing (constantly or upon its death) are not released into the bloodstream.
Just a guess!
Oh, and the image for the article is sideways - the right side seems to be what the caption refers to as "up".
Benjamin